[1] FEINSTONE S M, KAPIKIAN A Z, PURCELL R H, et al. Transfusion-associated hepatitis not due to viral hepatitis type A or B [J]. N Engl J Med, 1975, 292（15）: 767-70.
[2] BALAYAN M S, ANDJAPARIDZE A G, SAVINSKAYA S S, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route [J]. Intervirology, 1983, 20（1）: 23-31.
[3] BRADLEY D W, KRAWCZYNSKI K, COOK E H, JR., et al. Enterically transmitted non-A, non-B hepatitis: serial passage of disease in cynomolgus macaques and tamarins and recovery of disease-associated 27- to 34-nm viruslike particles [J]. Proc Natl Acad Sci U S A, 1987, 84（17）: 6277-81.
[4] ARANKALLE V A, TICEHURST J, SREENIVASAN M A, et al. Aetiological association of a virus-like particle with enterically transmitted non-A, non-B hepatitis [J]. Lancet, 1988, 1（8585）: 550-4.
[5] REYES G R, PURDY M A, KIM J P, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis [J]. Science, 1990, 247（4948）: 1335-9.
[6] TAM A W, SMITH M M, GUERRA M E, et al. Hepatitis E virus （HEV）: molecular cloning and sequencing of the full-length viral genome [J]. Virology, 1991, 185（1）: 120-31.
[7] ZHANG M, PURCELL R H, EMERSON S U. Identification of the 5' terminal sequence of the SAR-55 and MEX-14 strains of hepatitis E virus and confirmation that the genome is capped [J]. J Med Virol, 2001, 65（2）: 293-5.
[8] NAIR V P, ANANG S, SUBRAMANI C, et al. Endoplasmic Reticulum Stress Induced Synthesis of a Novel Viral Factor Mediates Efficient Replication of Genotype-1 Hepatitis E Virus [J]. PLoS Pathog, 2016, 12（4）: e1005521.
[9] KAMAR N, DALTON H R, ABRAVANEL F, et al. Hepatitis E virus infection [J]. Clin Microbiol Rev, 2014, 27（1）: 116-38.
[10] KOONIN E V, GORBALENYA A E, PURDY M A, et al. Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses [J]. Proc Natl Acad Sci U S A, 1992, 89（17）: 8259-63.
[11] ROZANOV M N, KOONIN E V, GORBALENYA A E. Conservation of the putative methyltransferase domain: a hallmark of the 'Sindbis-like' supergroup of positive-strand RNA viruses [J]. J Gen Virol, 1992, 73 （ Pt 8）: 2129-34.
[12] TSAREV S A, EMERSON S U, TSAREVA T S, et al. Variation in course of hepatitis E in experimentally infected cynomolgus monkeys [J]. J Infect Dis, 1993, 167（6）: 1302-6.
[13] FRY K E, TAM A W, SMITH M M, et al. Hepatitis E virus （HEV）: strain variation in the nonstructural gene region encoding consensus motifs for an RNA-dependent RNA polymerase and an ATP/GTP binding site [J]. Virus Genes, 1992, 6（2）: 173-85.
[14] KABRANE-LAZIZI Y, MENG X J, PURCELL R H, et al. Evidence that the genomic RNA of hepatitis E virus is capped [J]. J Virol, 1999, 73（10）: 8848-50.
[15] MAGDEN J, TAKEDA N, LI T, et al. Virus-specific mRNA capping enzyme encoded by hepatitis E virus [J]. J Virol, 2001, 75（14）: 6249-55.
[16] SHAFAT Z, HAMZA A, ISLAM A, et al. Structural exploration of Y-domain reveals its essentiality in HEV pathogenesis [J]. Protein Expr Purif, 2021, 187: 105947.
[17] KRAUSSLICH H G, NICKLIN M J, LEE C K, et al. Polyprotein processing in picornavirus replication [J]. Biochimie, 1988, 70（1）: 119-30.
[18] BOUFFARD P, BARTENSCHLAGER R, AHLBORN-LAAKE L, et al. An in vitro assay for hepatitis C virus NS3 serine proteinase [J]. Virology, 1995, 209（1）: 52-9.
[19] BONILLA P J, HUGHES S A, PINON J D, et al. Characterization of the leader papain-like proteinase of MHV-A59: identification of a new in vitro cleavage site [J]. Virology, 1995, 209（2）: 489-97.
[20] PANDA S K, ANSARI I H, DURGAPAL H, et al. The in vitrosynthesized RNA from a cDNA clone of hepatitis E virus is infectious [J]. J Virol, 2000, 74（5）: 2430-7.
[21] TYAGI S, SURJIT M, LAL S K. The 41-amino-acid C-terminal region of the hepatitis E virus ORF3 protein interacts with bikunin, a kunitz-type serine protease inhibitor [J]. J Virol, 2005, 79（18）: 12081-7.
[22] GEIDER K, HOFFMANN-BERLING H. Proteins controlling the helical structure of DNA [J]. Annu Rev Biochem, 1981, 50: 233-60.
[23] AGRAWAL S, GUPTA D, PANDA S K. The 3' end of hepatitis E virus （HEV） genome binds specifically to the viral RNA-dependent RNA polymerase （RdRp） [J]. Virology, 2001, 282（1）: 87-101.
[24] GRAFF J, NGUYEN H, YU C, et al. The open reading frame 3 gene of hepatitis E virus contains a cis-reactive element and encodes a protein required for infection of macaques [J]. J Virol, 2005, 79（11）: 6680-9.
[25] HANSEN J L, LONG A M, SCHULTZ S C. Structure of the RNA-dependent RNA polymerase of poliovirus [J]. Structure, 1997, 5（8）: 1109-22.
[26] LESBURG C A, CABLE M B, FERRARI E, et al. Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site [J]. Nat Struct Biol, 1999, 6（10）: 937-43.
[27] KAUR M, HYAMS K C, PURDY M A, et al. Human linear Bcell epitopes encoded by the hepatitis E virus include determinants in the RNA-dependent RNA polymerase [J]. Proc Natl Acad Sci U S A, 1992, 89（9）: 3855-8.
[28] PURDY M A, TAM A W, HUANG C C, et al. Hepatitis-E Virus - a Nonenveloped Member of the Alpha-Like Rna Virus Supergroup [J]. Semin Virol, 1993, 4（5）: 319-26.
[29] PANDA S K, NANDA S K, ZAFRULLAH M, et al. An Indian strain of hepatitis E virus （HEV）: cloning, sequence, and expression of structural region and antibody responses in sera from individuals from an area of high-level HEV endemicity [J]. J Clin Microbiol, 1995, 33（10）: 2653-9.
[30] JAMEEL S, ZAFRULLAH M, OZDENER M H, et al. Expression in animal cells and characterization of the hepatitis E virus structural proteins [J]. J Virol, 1996, 70（1）: 207-16.
[31] TORRESI J, MEANGER J, LAMBERT P, et al. High level expression of the capsid protein of hepatitis E virus in diverse eukaryotic cells using the Semliki Forest virus replicon [J]. J Virol Methods, 1997, 69（1-2）: 81-91.
[32] ROBINSON R A, BURGESS W H, EMERSON S U, et al. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells [J]. Protein Expr Purif, 1998, 12（1）: 75-84.
[33] CARL M, ISAACS S N, KAUR M, et al. Expression of hepatitis E virus putative structural proteins in recombinant vaccinia viruses [J]. Clin Diagn Lab Immunol, 1994, 1（2）: 253-6.
[34] TYAGI S, JAMEEL S, LAL S K. Self-association and mapping of the interaction domain of hepatitis E virus ORF3 protein [J]. J Virol, 2001, 75（5）: 2493-8.
[35] TORRESI J, LI F, LOCARNINI S A, et al. Only the nonglycosylated fraction of hepatitis E virus capsid （open reading frame 2）protein is stable in mammalian cells [J]. J Gen Virol, 1999, 80 （ Pt 5）: 1185-8.
[36] MCATEE C P, ZHANG Y, YARBOUGH P O, et al. Purification and characterization of a recombinant hepatitis E protein vaccine candidate by liquid chromatography-mass spectrometry [J]. J Chromatogr B Biomed Appl, 1996, 685（1）: 91-104.
[37] ZHANG Y, MCATEE P, YARBOUGH P O, et al. Expression, characterization, and immunoreactivities of a soluble hepatitis E virus putative capsid protein species expressed in insect cells [J]. Clin Diagn Lab Immunol, 1997, 4（4）: 423-8.
[38] LI T C, YAMAKAWA Y, SUZUKI K, et al. Expression and selfassembly of empty virus-like particles of hepatitis E virus [J]. J Virol, 1997, 71（10）: 7207-13.
[39] XING L, KATO K, LI T, et al. Recombinant hepatitis E capsid protein self-assembles into a dual-domain T = 1 particle presenting native virus epitopes [J]. Virology, 1999, 265（1）: 35-45.
[40] XIAOFANG L, ZAFRULLAH M, AHMAD F, et al. A CTerminal Hydrophobic Region is Required for Homo-Oligomerization of the Hepatitis E Virus Capsid （ORF2） Protein [J]. J Biomed Biotechnol, 2001, 1（3）: 122-8.
[41] SURJIT M, JAMEEL S, LAL S K. The ORF2 protein of hepatitis E virus binds the 5' region of viral RNA [J]. J Virol, 2004, 78（1）: 320-8.
[42] PINA S, BUTI M, COTRINA M, et al. HEV identified in serum from humans with acute hepatitis and in sewage of animal origin in Spain [J]. J Hepatol, 2000, 33（5）: 826-33.
[43] SCHLAUDER G G, MUSHAHWAR I K. Genetic heterogeneity of hepatitis E virus [J]. J Med Virol, 2001, 65（2）: 282-92.
[44] CLEMENTE-CASARES P, PINA S, BUTI M, et al. Hepatitis E virus epidemiology in industrialized countries [J]. Emerg Infect Dis, 2003, 9（4）: 448-54.
[45] REIN D B, STEVENS G A, THEAKER J, et al. The global burden of hepatitis E virus genotypes 1 and 2 in 2005 [J]. Hepatology, 2012, 55（4）: 988-97.
[46] RAYIS D A, JUMAA A M, GASIM G I, et al. An outbreak of hepatitis E and high maternal mortality at Port Sudan, Eastern Sudan [J]. Pathog Glob Health, 2013, 107（2）: 66-8.
[47] CLEMENTE-CASARES P, RAMOS-ROMERO C, RAMIREZGONZALEZ E, et al. Hepatitis E Virus in Industrialized Countries: The Silent Threat [J]. Biomed Res Int, 2016, 2016: 9838041.
[48] DITAH I, DITAH F, DEVAKI P, et al. Current epidemiology of hepatitis E virus infection in the United States: low seroprevalence in the National Health and Nutrition Evaluation Survey [J]. Hepatology, 2014, 60（3）: 815-22.
[49] DOMANOVIC D, TEDDER R, BLUMEL J, et al. Hepatitis E and blood donation safety in selected European countries: a shift to screening? [J]. Euro Surveill, 2017, 22（16）.
[50] MENG X J. Expanding Host Range and Cross-Species Infection of Hepatitis E Virus [J]. PLoS Pathog, 2016, 12（8）: e1005695.
[51] MYKYTCZUK O, HARLOW J, BIDAWID S, et al. Prevalence and Molecular Characterization of the Hepatitis E Virus in Retail Pork Products Marketed in Canada [J]. Food Environ Virol, 2017, 9（2）: 208-18.
[52] SZABO K, TROJNAR E, ANHEYER-BEHMENBURG H, et al. Detection of hepatitis E virus RNA in raw sausages and liver sausages from retail in Germany using an optimized method [J]. Int J Food Microbiol, 2015, 215: 149-56.
[53] PAVIO N, MERBAH T, THEBAULT A. Frequent hepatitis E virus contamination in food containing raw pork liver, France [J]. Emerg Infect Dis, 2014, 20（11）: 1925-7.
[54] WOO P C, LAU S K, TENG J L, et al. New Hepatitis E Virus Genotype in Bactrian Camels, Xinjiang, China, 2013 [J]. Emerg Infect Dis, 2016, 22（12）: 2219-21.
[55] WOO P C, LAU S K, TENG J L, et al. New hepatitis E virus genotype in camels, the Middle East [J]. Emerg Infect Dis, 2014, 20（6）: 1044-8.
[56] RASCHE A, SAQIB M, LILJANDER A M, et al. Hepatitis E Virus Infection in Dromedaries, North and East Africa, United Arab Emirates, and Pakistan, 1983-2015 [J]. Emerg Infect Dis, 2016, 22（7）: 1249-52.
[57] PEREZ-GRACIA M T, SUAY-GARCIA B, MATEOSLINDEMANN M L. Hepatitis E and pregnancy: current state [J]. Rev Med Virol, 2017, 27（3）: e1929.
[58] SHARAPOV M B, FAVOROV M O, YASHINA T L, et al. Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance data [J]. BMC Infect Dis, 2009, 9: 35.
[59] BORENTAIN P, COLSON P, BOLON E, et al. Hepatocellular carcinoma complicating hepatitis E virus-related cirrhosis [J]. Hepatology, 2018, 67（1）: 446-8.
[60] KAMAR N, GARROUSTE C, HAAGSMA E B, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants [J]. Gastroenterology, 2011, 140（5）: 1481-9.
[61] DEBING Y, RAMIERE C, DALLMEIER K, et al. Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity [J]. J Hepatol, 2016, 65（3）: 499-508.
[62] ZHAO Q, ZHANG J, WU T, et al. Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy [J]. J Gastroenterol, 2013, 48（2）: 159-68.
[63] TSAREV S A, TSAREVA T S, EMERSON S U, et al. Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge [J]. Vaccine, 1997, 15（17-18）: 1834-8.
[64] NIMGAONKAR I, DING Q, SCHWARTZ R E, et al. Hepatitis E virus: advances and challenges [J]. Nat Rev Gastroenterol Hepatol, 2018, 15（2）: 96-110.
[65] CHALUPA P, HOLUB M. Jaundice complicated by an atypical form of Guillain-Barre syndrome [J]. J Clin Virol, 2010, 49（4）: 229-30.
[66] DIXIT V K, ABHILASH V B, KATE M P, et al. Hepatitis E infection with Bell's palsy [J]. J Assoc Physicians India, 2006, 54: 418.
[67] FONG F, ILLAHI M. Neuralgic amyotrophy associated with hepatitis E virus [J]. Clin Neurol Neurosurg, 2009, 111（2）: 193-5.
[68] MANDAL K, CHOPRA N. Acute transverse myelitis following hepatitis E virus infection [J]. Indian Pediatr, 2006, 43（4）: 365-6.
[69] KEJARIWAL D, ROY S, SARKAR N. Seizure associated with acute hepatitis E [J]. Neurology, 2001, 57（10）: 1935.
[70] KAMAR N, BENDALL R P, PERON J M, et al. Hepatitis E virus and neurologic disorders [J]. Emerg Infect Dis, 2011, 17（2）: 173-9.
[71] DEL BELLO A, ARNE-BES M C, LAVAYSSIERE L, et al. Hepatitis E virus-induced severe myositis [J]. J Hepatol, 2012, 57（5）: 1152-3.
[72] KAMAR N, IZOPET J, CINTAS P, et al. Hepatitis E virusinduced neurological symptoms in a kidney-transplant patient with chronic hepatitis [J]. Am J Transplant, 2010, 10（5）: 1321-4.
[73] MAURISSEN I, JEURISSEN A, STRAUVEN T, et al. First case of anti-ganglioside GM1-positive Guillain-Barre syndrome due to hepatitis E virus infection [J]. Infection, 2012, 40（3）: 323-6.
[74] KAMAR N, WECLAWIAK H, GUILBEAU-FRUGIER C, et al. Hepatitis E virus and the kidney in solid-organ transplant patients [J]. Transplantation, 2012, 93（6）: 617-23.
[75] THAPA R, BISWAS B, MALLICK D, et al. Acute pancreatitis--complicating hepatitis E virus infection in a 7-year-old boy with glucose 6 phosphate dehydrogenase deficiency [J]. Clin Pediatr （Phila）, 2009, 48（2）: 199-201.
[76] SHAH S A, LAL A, IDREES M, et al. Hepatitis E virusassociated aplastic anaemia: the first case of its kind [J]. J Clin Virol, 2012, 54（1）: 96-7.
[77] KAMERKAR S C, KRAUS F, SHARPE A J, et al. Dynaminrelated protein 1 has membrane constricting and severing abilities sufficient for mitochondrial and peroxisomal fission [J]. Nat Commun, 2018, 9（1）: 5239.
[78] VARADI A, JOHNSON-CADWELL L I, CIRULLI V, et al. Cytoplasmic dynein regulates the subcellular distribution of mitochondria by controlling the recruitment of the fission factor dynamin-related protein-1 [J]. J Cell Sci, 2004, 117（Pt 19）: 4389-400.
[79] KATAJISTO P, DOHLA J, CHAFFER C L, et al. Stem cells. Asymmetric apportioning of aged mitochondria between daughter cells is required for stemness [J]. Science, 2015, 348（6232）: 340-3.
[80] MOORE A S, COSCIA S M, SIMPSON C L, et al. Actin cables and comet tails organize mitochondrial networks in mitosis [J]. Nature, 2021, 591（7851）: 659-64.
[81] WAI T, LANGER T. Mitochondrial Dynamics and Metabolic Regulation [J]. Trends Endocrin Met, 2016, 27（2）: 105-17.
[82] YOSHIZUMI T, ICHINOHE T, SASAKI O, et al. Influenza A virus protein PB1-F2 translocates into mitochondria via Tom40 channels and impairs innate immunity [J]. Nat Commun, 2014, 5: 4713.
[83] KIM S J, SYED G H, KHAN M, et al. Hepatitis C virus triggers mitochondrial fission and attenuates apoptosis to promote viral persistence [J]. Proc Natl Acad Sci U S A, 2014, 111（17）: 6413-8.
[84] CHATEL-CHAIX L, CORTESE M, ROMERO-BREY I, et al. Dengue Virus Perturbs Mitochondrial Morphodynamics to Dampen Innate Immune Responses [J]. Cell Host Microbe, 2016, 20（3）: 342-56.
[85] CASTANIER C, GARCIN D, VAZQUEZ A, et al. Mitochondrial dynamics regulate the RIG-I-like receptor antiviral pathway [J]. EMBO Rep, 2010, 11（2）: 133-8.
[86] ZHOU R, YAZDI A S, MENU P, et al. A role for mitochondria in NLRP3 inflammasome activation [J]. Nature, 2011, 469（7329）: 221-5.
[87] IYER S S, HE Q, JANCZY J R, et al. Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation [J]. Immunity, 2013, 39（2）: 311-23.
[88] ALLEN I C, SCULL M A, MOORE C B, et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA [J]. Immunity, 2009, 30（4）: 556-65.
[89] DASHDORJ A, JYOTHI K R, LIM S, et al. Mitochondriatargeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines [J]. BMC Med, 2013, 11: 178.
[90] ABARCA-ROJANO E, MUNIZ-HERNANDEZ S, MORENOALTAMIRANO M M, et al. Re-organization of mitochondria at the NK cell immune synapse [J]. Immunol Lett, 2009, 122（1）: 18-25.
[91] HORBAY R, BILYY R. Mitochondrial dynamics during cell cycling [J]. Apoptosis, 2016, 21（12）: 1327-35.
[92] LEE Y I, HWANG J M, IM J H, et al. Human hepatitis B virusX protein alters mitochondrial function and physiology in human liver cells [J]. J Biol Chem, 2004, 279（15）: 15460-71.
[93] BARBARO G, DI LORENZO G, ASTI A, et al. Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings [J]. Am J Gastroenterol, 1999, 94（8）: 2198-205.
[94] KEATING D J. Mitochondrial dysfunction, oxidative stress, regulation of exocytosis and their relevance to neurodegenerative diseases [J]. J Neurochem, 2008, 104（2）: 298-305.
[95] KIM S J, KHAN M, QUAN J, et al. Hepatitis B virus disrupts mitochondrial dynamics: induces fission and mitophagy to attenuate apoptosis [J]. PLoS Pathog, 2013, 9（12）: e1003722.
[96] VARGA Z T, GRANT A, MANICASSAMY B, et al. Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential [J]. J Virol, 2012, 86（16）: 8359-66.
[97] YU C Y, LIANG J J, LI J K, et al. Dengue Virus Impairs Mitochondrial Fusion by Cleaving Mitofusins [J]. PLoS Pathog, 2015, 11（12）: e1005350.
[98] KIM S J, AHN D G, SYED G H, et al. The essential role of mitochondrial dynamics in antiviral immunity [J]. Mitochondrion, 2018, 41: 21-7.
[99] MCCORMICK A L, SMITH V L, CHOW D, et al. Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis [J]. J Virol, 2003, 77（1）: 631-41.
修改评论